Retatrutide is an investigational clinical program.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Retatrutide is an investigational clinical program. No seller listing in Switzerland can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Resolve the exact identity of Retatrutide through TRIUMPH-1 Phase 3 study - NCT05929066 from ClinicalTrials.gov. Then search Lists of authorized medicinal products from Swissmedic for the destination product record and Guideline on medicines and the Internet from Swissmedic for the seller, establishment, or supply route in Switzerland. A match in one record does not replace the other two checks.
No. A page using the name Retatrutide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Switzerland, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
1 study records currently list 3 locations in this country, including 0 locations individually marked Recruiting.
Registry update: 24 July 2026Retatrutide is an investigational clinical program. No seller listing in Switzerland can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Primary identity source: TRIUMPH-1 Phase 3 study - NCT05929066 / ClinicalTrials.gov ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
TRIUMPH-1 Phase 3 study - NCT05929066 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open TRIUMPH-1 Phase 3 study - NCT05929066 ↗Lists of authorized medicinal products is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Lists of authorized medicinal products ↗Guideline on medicines and the Internet is maintained by Swissmedic. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Guideline on medicines and the Internet ↗Swiss medicine authorization and online dispensing are different checks. Swissmedic publishes current authorized-product information, while mail-order dispensing involves legal conditions and cantonal licensing that a foreign seller claim cannot establish.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use Swissmedic's current lists and product-information platform to match the exact medicine, pack, authorization holder, and status instead of extrapolating from an active-substance name.
Read Swissmedic's internet-medicine guidance and verify the relevant cantonal mail-order licence. A Swiss-looking domain or address is not evidence of that permission.
Import conditions, a customs outcome, and local licensed dispensing are different routes. Record which one an offer claims before comparing price or availability.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.